Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep;7(Suppl 6):S180.
doi: 10.21037/atm.2019.07.47.

Stereotactic body radiotherapy for oligometastatic renal cell carcinoma-are we ready to roll?

Christian C Okoye  1 , Ravi B Patel  2 , Shankar Siva  3 , Alexander V Louie  4 , Simon S Lo  5
Affiliations
Editorial

Stereotactic body radiotherapy for oligometastatic renal cell carcinoma-are we ready to roll?

Christian C Okoye et al. Ann Transl Med. 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Shankar Siva reports grants from Varian Industries outside the submitted work; Alexander V. Louie reports personal fees from Varian Medical Systems Inc. outside the submitted work; Simon S. Lo reports research support from Elekta AB in Elekta Gamma Knife ICON Expert Group outside of submitted work. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Flanigan RC, Campbell SC, Clark JI, et al. Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003;4:385-90. 10.1007/s11864-003-0039-2 - DOI - PubMed
    1. Alt AL, Boorjian SA, Lohse CM, et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011;117:2873-82. 10.1002/cncr.25836 - DOI - PubMed
    1. Zaid HB, Parker WP, Safdar NS, et al. Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: a systematic review and meta-analysis. J Urol 2017;197:44-9. 10.1016/j.juro.2016.07.079 - DOI - PubMed
    1. Meyer CP, Sun M, Karam JA, et al. Complications after metastasectomy for renal cell carcinoma-a population-based assessment. Eur Urol 2017;72:171-4. 10.1016/j.eururo.2017.03.005 - DOI - PubMed
    1. Widder J, Klinkenberg TJ, Ubbels JF, et al. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 2013;107:409-13. 10.1016/j.radonc.2013.05.024 - DOI - PubMed